Mitsuyasu Rt

430 total citations
12 papers, 349 citations indexed

About

Mitsuyasu Rt is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Mitsuyasu Rt has authored 12 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Genetics and 4 papers in Immunology. Recurrent topics in Mitsuyasu Rt's work include Immunodeficiency and Autoimmune Disorders (4 papers), HIV Research and Treatment (3 papers) and Viral-associated cancers and disorders (3 papers). Mitsuyasu Rt is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (4 papers), HIV Research and Treatment (3 papers) and Viral-associated cancers and disorders (3 papers). Mitsuyasu Rt collaborates with scholars based in United States, Georgia and India. Mitsuyasu Rt's co-authors include Glaspy Ja, J Moreno, N. Kirby Alton, L Souza, Gayle Cocita Baldwin, L Souza, KM Zsebo, S O'Rourke, Roger Detels and J. C. Samantaray and has published in prestigious journals such as Blood, AIDS Research and Treatment and PubMed.

In The Last Decade

Mitsuyasu Rt

12 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsuyasu Rt United States 9 149 121 111 84 82 12 349
Glaspy Ja United States 9 138 0.9× 49 0.4× 47 0.4× 107 1.3× 47 0.6× 12 299
Françoise Roudot‐Thoraval France 6 51 0.3× 78 0.6× 45 0.4× 93 1.1× 144 1.8× 8 316
Karl W. Sykora Germany 12 47 0.3× 28 0.2× 67 0.6× 97 1.2× 67 0.8× 15 302
C. Rabian France 10 83 0.6× 50 0.4× 70 0.6× 51 0.6× 79 1.0× 15 345
Claire‐Michèle Farber Belgium 10 65 0.4× 32 0.3× 82 0.7× 20 0.2× 66 0.8× 16 272
Romain Lévy France 8 32 0.2× 63 0.5× 77 0.7× 90 1.1× 58 0.7× 13 276
Odile Avinens France 9 37 0.2× 200 1.7× 102 0.9× 33 0.4× 58 0.7× 10 381
M Bofill Spain 7 37 0.2× 100 0.8× 99 0.9× 32 0.4× 58 0.7× 8 404
B. Völkers Germany 10 133 0.9× 53 0.4× 39 0.4× 411 4.9× 15 0.2× 14 558
Dawn R. Clark United States 9 35 0.2× 125 1.0× 111 1.0× 32 0.4× 84 1.0× 12 422

Countries citing papers authored by Mitsuyasu Rt

Since Specialization
Citations

This map shows the geographic impact of Mitsuyasu Rt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuyasu Rt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuyasu Rt more than expected).

Fields of papers citing papers by Mitsuyasu Rt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuyasu Rt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuyasu Rt. The network helps show where Mitsuyasu Rt may publish in the future.

Co-authorship network of co-authors of Mitsuyasu Rt

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuyasu Rt. A scholar is included among the top collaborators of Mitsuyasu Rt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuyasu Rt. Mitsuyasu Rt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sinha, Sanjeev, Hafiz Ahmad, Rahul Shekhar, et al.. (2012). Prevalence of HIV Drug Resistance Mutations in HIV Type 1 Isolates in Antiretroviral Therapy Naïve Population from Northern India. AIDS Research and Treatment. 2012. 1–6. 19 indexed citations
2.
Ps, Gill, et al.. (1997). AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.. PubMed. 3(5). 278–83. 11 indexed citations
3.
O'Rourke, S, et al.. (1994). Phenotypically defined memory CD4+ cells are not selectively decreased in chronic HIV disease.. PubMed. 7(7). 665–75. 28 indexed citations
4.
Rt, Mitsuyasu. (1993). Clinical uses of hematopoietic growth hormones in HIV-related illnesses.. PubMed. 189–212. 9 indexed citations
5.
Zsebo, KM, et al.. (1991). Potential use of human stem cell factor as adjunctive therapy for human immunodeficiency virus-related cytopenias. Blood. 78(12). 3200–3208. 28 indexed citations
6.
Rt, Mitsuyasu, et al.. (1991). Syngeneic bone-marrow transplantation and failure to eradicate HIV.. PubMed. 5(3). 344–344. 13 indexed citations
7.
Rt, Mitsuyasu, J Moreno, Gayle Cocita Baldwin, et al.. (1991). Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood. 77(10). 2109–2117. 5 indexed citations
8.
Rt, Mitsuyasu, J Moreno, Gayle Cocita Baldwin, et al.. (1991). Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood. 77(10). 2109–2117. 110 indexed citations
9.
10.
11.
Rt, Mitsuyasu, et al.. (1988). Biotherapy with interferon in AIDS-related Kaposi's sarcoma.. PubMed. 14(6 Suppl). 27–31. 1 indexed citations
12.
Rt, Mitsuyasu, et al.. (1984). Biology and therapy of Kaposi's sarcoma.. PubMed. 11(1). 53–9. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Glaspy Ja Breakdown of academic impact, for papers by Françoise Roudot‐Thoraval Breakdown of academic impact, for papers by Karl W. Sykora Breakdown of academic impact, for papers by C. Rabian Breakdown of academic impact, for papers by Claire‐Michèle Farber Breakdown of academic impact, for papers by Romain Lévy Breakdown of academic impact, for papers by Odile Avinens Breakdown of academic impact, for papers by M Bofill Breakdown of academic impact, for papers by B. Völkers Breakdown of academic impact, for papers by Dawn R. Clark
Rankless by CCL
2026